- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
8
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
8 companies
AbbVie
Market Cap: US$399.6b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$226.87
7D
-1.7%
1Y
20.3%
Alnylam Pharmaceuticals
Market Cap: US$61.6b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$481.07
7D
5.3%
1Y
62.1%
Ligand Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$180.77
7D
-0.9%
1Y
70.7%
Rhythm Pharmaceuticals
Market Cap: US$7.3b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$111.18
7D
10.9%
1Y
117.9%
BioLife Solutions
Market Cap: US$1.4b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$27.73
7D
1.0%
1Y
19.8%
Caris Life Sciences
Market Cap: US$8.8b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$31.95
7D
2.2%
1Y
n/a
Eli Lilly
Market Cap: US$742.0b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$819.38
7D
-4.2%
1Y
-10.7%
Sotera Health
Market Cap: US$4.6b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$16.33
7D
3.5%
1Y
3.6%